Browse

You are looking at 1 - 2 of 2 items for :

  • Carney complex x
Clear All
Catherine D Zhang Departments of Internal Medicine, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, Minnesota, USA

Search for other papers by Catherine D Zhang in
Google Scholar
PubMed
Close
,
Pavel N Pichurin Departments of Clinical Genomics, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, Minnesota, USA

Search for other papers by Pavel N Pichurin in
Google Scholar
PubMed
Close
,
Aleh Bobr Departments of Laboratory Medicine and Pathology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, Minnesota, USA

Search for other papers by Aleh Bobr in
Google Scholar
PubMed
Close
,
Melanie L Lyden Departments of Surgery, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, Minnesota, USA

Search for other papers by Melanie L Lyden in
Google Scholar
PubMed
Close
,
William F Young Jr Departments of Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, Minnesota, USA

Search for other papers by William F Young Jr in
Google Scholar
PubMed
Close
, and
Irina Bancos Departments of Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, Minnesota, USA

Search for other papers by Irina Bancos in
Google Scholar
PubMed
Close

Summary

Carney complex (CNC) is a rare multiple neoplasia syndrome characterized by spotty pigmentation of the skin and mucosa in association with various non-endocrine and endocrine tumors, including primary pigmented nodular adrenocortical disease (PPNAD). A 20-year-old woman was referred for suspected Cushing syndrome. She had signs of cortisol excess as well as skin lentigines on physical examination. Biochemical investigation was suggestive of corticotropin (ACTH)-independent Cushing syndrome. Unenhanced computed tomography scan of the abdomen did not reveal an obvious adrenal mass. She subsequently underwent bilateral laparoscopic adrenalectomy, and histopathology was consistent with PPNAD. Genetic testing revealed a novel frameshift pathogenic variant c.488delC/p.Thr163MetfsX2 (ClinVar Variation ID: 424516) in the PRKAR1A gene, consistent with clinical suspicion for CNC. Evaluation for other clinical features of the complex was unrevealing. We present a case of PPNAD-associated Cushing syndrome leading to the diagnosis of CNC due to a novel PRKAR1A pathogenic variant.

Learning points:

  • PPNAD should be considered in the differential for ACTH-independent Cushing syndrome, especially when adrenal imaging appears normal.

  • The diagnosis of PPNAD should prompt screening for CNC.

  • CNC is a rare multiple neoplasia syndrome caused by inactivating pathogenic variants in the PRKAR1A gene.

  • Timely diagnosis of CNC and careful surveillance can help prevent potentially fatal complications of the disease.

Open access
Shweta Birla Laboratory of Cyto-Molecular Genetics, Department of Anatomy

Search for other papers by Shweta Birla in
Google Scholar
PubMed
Close
,
Sameer Aggarwal Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi, India

Search for other papers by Sameer Aggarwal in
Google Scholar
PubMed
Close
,
Arundhati Sharma Laboratory of Cyto-Molecular Genetics, Department of Anatomy

Search for other papers by Arundhati Sharma in
Google Scholar
PubMed
Close
, and
Nikhil Tandon Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi, India

Search for other papers by Nikhil Tandon in
Google Scholar
PubMed
Close

Summary

Carney complex (CNC) is a rare autosomal dominant syndrome characterized by pigmented lesions of the skin and mucosae along with cardiac, endocrine, cutaneous, and neural myxomatous tumors. Mutations in the PRKAR1A gene have been identified in ∼70% of the CNC cases reported worldwide. A 30-year-old male was referred to the endocrinology clinic with suspected acromegaly. He had a history of recurrent atrial myxoma for the past 8 years for which he underwent repeated surgeries. Presently, he complained of having headache, excessive snoring, sweating, and also noticed increase in his shoe size. Evaluation for acromegaly revealed elevated levels of GH in random as well as in suppressed condition. Magnetic resonance imaging scan revealed enlarged sella with microadenoma in the left anterior pituitary. Screening of PRKAR1A gene was carried out for the patient, his parents and siblings who were available and willing to undergo the test. The patient was diagnosed to have the rare CNC syndrome characterized by recurrent atrial myxoma and acromegaly due to a novel 22 bp insertion mutation in PRKAR1A which was predicted to be deleterious by in silico analysis. Screening the available family members revealed the absence of this mutation in them except the elder brother who also tested positive for this mutation. The present study reports on a novel PRKAR1A insertion mutation in a patient with acromegaly and left atrial myxoma in CNC.

Learning points

  • Identification of a novel deleterious PRKAR1A insertion mutation causing CNC.

  • It is important that patients with cardiac myxoma be investigated for presence of endocrine overactivity suggestive of CNC.

  • PRKAR1A mutation analysis should be undertaken in such cases to confirm the diagnosis in the patients as well as first degree relatives.

  • This case highlights an important aspect of diagnosis, clinical course, and management of this rare condition.

Open access